These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 833415

  • 1. Procaine hydrochloride as a monoamine oxidase inhibitor: implications for Geriatric therapy.
    Fuller RW, Roush BW.
    J Am Geriatr Soc; 1977 Feb; 25(2):90-3. PubMed ID: 833415
    [Abstract] [Full Text] [Related]

  • 2. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA, Zagorevskiĭ VA, Lopatina KI, Sokolova TV, Gankina EM.
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [Abstract] [Full Text] [Related]

  • 3. Deamination of 5-methoxytryptamine, serotonin and phenylethylamine by rat MAO in vitro and in vivo.
    Prozialek WC, Vogel WH.
    Life Sci; 1978 Feb; 22(7):561-9. PubMed ID: 272480
    [No Abstract] [Full Text] [Related]

  • 4. Differential substrate specificity of monoamine oxidase in the rat heart and renal cortex.
    Guimarães JT, Vindis C, Soares-da-Silva P, Parini A.
    Life Sci; 2003 Jul 11; 73(8):955-67. PubMed ID: 12818349
    [Abstract] [Full Text] [Related]

  • 5. Multiple binding sites of human brain and liver monoamine oxidase: substrate specificities, selective inhibitions, and attempts to separate enzyme forms.
    White HL, Glassman AT.
    J Neurochem; 1977 Dec 11; 29(6):987-97. PubMed ID: 599351
    [No Abstract] [Full Text] [Related]

  • 6. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW, Hemrick-Luecke SK, Kindt MV, Heikkila RE.
    Life Sci; 1988 Dec 11; 42(3):263-71. PubMed ID: 3121972
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine.
    Kitaichi Y, Inoue T, Nakagawa S, Boku S, Izumi T, Koyama T.
    Eur J Pharmacol; 2010 Jul 10; 637(1-3):77-82. PubMed ID: 20406628
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Murine regional brain monoamine oxidase activity: time- and age-dependent response to inhibitors.
    Bhaskaran D, Radha E.
    Gerontology; 1984 Jul 10; 30(2):87-93. PubMed ID: 6706127
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Selective inhibition of type A monoamine oxidase by pyrazidol].
    Mashkovskiĭ MD, Gorkin VZ, Verevkina IV, Asnina VV, Tupikina SM.
    Biull Eksp Biol Med; 1981 Feb 10; 91(2):169-71. PubMed ID: 7225552
    [Abstract] [Full Text] [Related]

  • 14. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS.
    Biokhimiia; 1979 Feb 10; 44(2):195-207. PubMed ID: 435561
    [Abstract] [Full Text] [Related]

  • 15. Monoamine oxidase type A: differences in selectivity towards l-norepinephrine compared to serotonin.
    Garrick NA, Murphy DL.
    Biochem Pharmacol; 1982 Dec 15; 31(24):4061-6. PubMed ID: 7159481
    [Abstract] [Full Text] [Related]

  • 16. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW.
    Arch Int Pharmacodyn Ther; 1968 Jul 15; 174(1):32-7. PubMed ID: 4386711
    [No Abstract] [Full Text] [Related]

  • 17. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N, Barneoud P, Carter C, Caille D, Sontag N, Marc C, Lolivier J, Gardes A, Perron C, Le Kim A, Charieras T, Pandini M, Burnier P, Puech F, Jegham S, George P, Scatton B, Curet O.
    J Pharmacol Exp Ther; 2004 Sep 15; 310(3):1171-82. PubMed ID: 15178694
    [Abstract] [Full Text] [Related]

  • 18. Steric influence on inhibition of monoamine oxidase forms by 2,3-dichloro-alpha-methylbenzylamine.
    Fuller RW, Hemrick SK.
    Res Commun Chem Pathol Pharmacol; 1978 Apr 15; 20(1):199-202. PubMed ID: 663404
    [Abstract] [Full Text] [Related]

  • 19. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E, Reibert R.
    Arzneimittelforschung; 1984 Apr 15; 34(10):1258-60. PubMed ID: 6542783
    [Abstract] [Full Text] [Related]

  • 20. Extraneuronal monoamine oxidase in rat heart: biochemical characterization and electron microscopic localization.
    Lowe MC, Reichenbach DD, Horita A.
    J Pharmacol Exp Ther; 1975 Sep 15; 194(3):522-36. PubMed ID: 1159629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.